Secondary (AA) Amyloidosis
1 clinical trials · Condition
◉ Watch Secondary (AA) Amyloidosis
| Record | Firm | Date |
|---|---|---|
| Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis (NCT00035334) | Bellus Health Inc. - a GSK company | 2001-10-01 |
Track Secondary (AA) Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.